Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:829

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansson, G.
Right arrow Articles by Pepper, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansson, G.
Right arrow Articles by Pepper, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:829.)
© 1999 American Heart Association, Inc.


In Memoriam

Tribute to Werner Risau

December 18, 1953–December 13, 1998

Goran Hansson, Chairman, EVBA
Peter Carmeliet, Secretary, EVBA
Michael Pepper, Treasurer, EVBA
From 1995 to 1998, Werner Risau was Chairman of the European Vascular Biology Association (EVBA), which for many years has been closely associated with Arteriosclerosis, Thrombosis, and Vascular Biology. As the current officers of the EVBA board, we have had the privilege of working closely with Werner, both on scientific as well as administrative matters. In addition, we have collaborated extensively with Werner on various scientific projects.

Very early on in his brilliant career, it became clear that Werner had some very strong (usually correct) ideas about the mechanisms of angiogenesis, often in contradiction to established dogma. One of the most notable was his insistence, shortly after the discovery of VEGF, that bFGF is not the most important angiogenic factor and that it may in fact only play a minor (if any) role in the endogenous regulation of this process. Although the FGF saga continues despite a large amount of negative data, it is fair to say that Werner's intuition is proving to be correct. More recently, Werner insisted that angiopoietin 1 is involved not only in regulating vessel wall assembly but also in the process of capillary sprouting. Once again, his intuition is proving to be correct. One of Werner's hallmarks was his ability to conduct science in a collaborative manner, often involving several investigators and laboratories to solve an important problem. His dedication to deliver high-quality research has been a consistent feature of his scientific career. Many researchers, both established experts as well as young newcomers to the . . . [Full Text of this Article]